Bora Pharmaceuticals Completes Acquisition of Former GSK Facility

Broadens its range of dosage forms and enables the CDMO to produce 50 different products to 100 markets worldwide.

By: Contract Pharma

Contract Pharma Staff

Bora Pharmaceuticals Co., Ltd. recently announced that the contract development and manufacturing organization (CDMO) has successfully completed the acquisition of GSK’s Mississauga, Ontario (Canada) facility.   Initially announced in March 2020, the site represents Bora Pharmaceuticals’ first manufacturing facility in North America and will become home to its North American headquarters.   Establishing the Mississauga site as a core part of the CDMO’s global manufacturing network is part of a l...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters